Lv23
200 积分 2025-03-26 加入
Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1
2小时前
待确认
The multifaceted role of MUC1 in tumor therapy resistance
1天前
已完结
PP2A Promotes the Symmetric Division of MUC1‐Dominant Cancer Stem‐Like Cells in Small Cell Lung Cancer
1天前
已完结
DS-3939a: A TA-MUC1-directed Antibody-Drug Conjugate with Broad Anti-Tumor Activity
1天前
已完结
Multifunctional DNA nano-sponge system for targeted sensitization of ovarian cancer chemotherapy via metabolic reprogramming and ferroptosis induction
2天前
已完结
CHO Cell Line Development and Engineering via Site-specific Integration: Challenges and Opportunities
1个月前
已完结
A phase 1/2, first-in-human study of DS-3939a in patients with advanced solid tumors: A new DXd ADC targeting TA-MUC1
1个月前
已关闭
DS-3939a: A TA-MUC1-directed Antibody-Drug Conjugate with Broad Anti-Tumor Activity
1个月前
已完结
MUC1: An emerging target in cancer treatment and diagnosis
4个月前
已完结
Mucins as anti-cancer targets: perspectives of the glycobiologist
4个月前
已完结
皖公网安备34019202002308
